{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:12:44Z","timestamp":1762917164226},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,12,12]],"date-time":"2008-12-12T00:00:00Z","timestamp":1229040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s10620-008-0632-0","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T22:21:25Z","timestamp":1229034085000},"page":"2519-2522","source":"Crossref","is-referenced-by-count":47,"title":["Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience"],"prefix":"10.1007","volume":"54","author":[{"given":"David C.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizza","family":"Bojito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Facciuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Lebovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,12]]},"reference":[{"key":"632_CR1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","volume":"33","author":"PD Richardson","year":"2000","unstructured":"Richardson PD, James PD, Ryder SD. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol. 2000;33:371\u2013375. doi: 10.1016\/S0168-8278(00)80271-8 .","journal-title":"J Hepatol"},{"key":"632_CR2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","volume":"18","author":"SM Devlin","year":"2004","unstructured":"Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate moftil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can J Gastroenterol. 2004;18:321\u2013326.","journal-title":"Can J Gastroenterol"},{"key":"632_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","volume":"25","author":"N Chatur","year":"2005","unstructured":"Chatur N, Ramji A, Bain VG, et al. Transplant immunosupressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int. 2005;25:723\u2013727. doi: 10.1111\/j.1478-3231.2005.01107.x .","journal-title":"Liver Int"},{"key":"632_CR4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","volume":"39","author":"AJ Czaja","year":"2005","unstructured":"Czaja AJ, Carpenter HA. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease. J Clin Gastroenterol. 2005;39:819\u2013825. doi: 10.1097\/01.mcg.0000177260.72692.e8 .","journal-title":"J Clin Gastroenterol"},{"key":"632_CR5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","volume":"5","author":"I Inductivo-Yu","year":"2007","unstructured":"Inductivo-Yu I, Adams A, Gish RG, et al. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. Clin Gastroenterol Hepatol. 2007;5:799\u20138082. doi: 10.1016\/j.cgh.2007.02.030 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"632_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK. AASLD practice guidelines: diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479\u2013497. doi: 10.1053\/jhep.2002.34944 .","journal-title":"Hepatology"},{"key":"632_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","volume":"44","author":"O Chazouilleres","year":"2006","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Rosmordgue O, Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol. 2006;44:400\u2013406. doi: 10.1016\/j.jhep.2005.10.017 .","journal-title":"J Hepatol"},{"key":"632_CR8","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","volume":"100","author":"A Floreani","year":"2005","unstructured":"Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005;100:1516\u20131522. doi: 10.1111\/j.1572-0241.2005.41841.x .","journal-title":"Am J Gastroenterol"},{"key":"632_CR9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill WHJ, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820\u2013833.","journal-title":"Gastroenterology"},{"key":"632_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","volume":"1","author":"IM Murray-Lyon","year":"1973","unstructured":"Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973;1:735\u2013737. doi: 10.1016\/S0140-6736(73)92125-9 .","journal-title":"Lancet"},{"key":"632_CR11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","volume":"333","author":"PJ Johnson","year":"1995","unstructured":"Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med. 1995;333:958\u2013963. doi: 10.1056\/NEJM199510123331502 .","journal-title":"N Engl J Med"},{"key":"632_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","volume":"25","author":"J Wiegand","year":"2005","unstructured":"Wiegand J, Schuler A, Kanzler S, et al. Budesonide in previously untreated autoimmune hepatitis. Liver Int. 2005;25:927\u2013934. doi: 10.1111\/j.1478-3231.2005.01122.x .","journal-title":"Liver Int"},{"key":"632_CR13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3748\/wjg.v12.i9.1362","volume":"12","author":"A Csepregi","year":"2006","unstructured":"Csepregi A, Rocken C, Treiber G, Malfertheiner P. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol. 2006;12:1362\u20131366.","journal-title":"World J Gastroenterol"},{"key":"632_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","volume":"94","author":"NF Fernandes","year":"1999","unstructured":"Fernandes NF, Redeker AG, Vierling JM, Villamil FG, Fong TL. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol. 1999;94:241\u2013248. doi: 10.1111\/j.1572-0241.1999.00807.x .","journal-title":"Am J Gastroenterol"},{"key":"632_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MPG.0b013e31802c8aa3","volume":"44","author":"M Cuarterolo","year":"2007","unstructured":"Cuarterolo M, Ciocca M, Velasco CC, et al. Follow-up of children with autoimmune hepatitis treated with cyclosporine. J Pediatr Gastroenterol Nutr. 2007;44:18\u201319.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"632_CR16","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i26.3610","volume":"13","author":"FS Larsen","year":"2007","unstructured":"Larsen FS, Vainer B, Eefsen M, Bjjerring PN, Adel Hansen B. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol. 2007;13:3232\u20133236.","journal-title":"World J Gastroenterol"},{"key":"632_CR17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/lt.20453","volume":"11","author":"RH Wiesner","year":"2005","unstructured":"Wiesner RH, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Lake JR. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl. 2005;11:750\u2013759. doi: 10.1002\/lt.20453 .","journal-title":"Liver Transpl"},{"key":"632_CR18","unstructured":"United States Food and Drug Administration. MedWatch. www.fda.gov\/medwatch\/safety\/2007\/safety07.htm#CellCept2 . Posted 29 October 2007. Accessed 19 November 2008."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0632-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0632-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:42:45Z","timestamp":1559245365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0632-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,12]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0632-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,12]]}}}